NSE
BSEThe Quarter story
The two most recent quarterly results, compared side-by-side.
Dr Agarwals expands its facility network and doctor headcount organically, driving consistent revenue growth while steadily cutting gross debt.
Revenue from Operations grows from ₹487 Cr to ₹614 Cr from Q1 FY26 to Q1 FY27 — steady top-line expansion across all regions
Cash and Cash Equivalents [Investments in Fixed Deposits] falls from ₹104 Cr to ₹19 Cr from Q1 FY26 to Q1 FY27 — portfolio liquidation funds ongoing expansion
Number of Facilities expands from 63 to 304 from Q1 FY26 to Q1 FY27 — organic network scaling drives patient access
Cost of Goods Sold rises from ₹110 Cr to ₹130 Cr from Q1 FY26 to Q1 FY27 — higher input costs pressure gross margins
Doctors increase from 857 to 1,057 from Q1 FY26 to Q1 FY27 — larger clinical team supports higher surgery volumes
Employee benefits expense climbs from ₹96 Cr to ₹121 Cr from Q1 FY26 to Q1 FY27 — scaling headcount increases operational overhead
Gross Debt falls from ₹175 Cr to ₹78 Cr from Q1 FY26 to Q1 FY27 — aggressive deleveraging strengthens the balance sheet
Net Debt shifts from -₹278 Cr to ₹12 Cr from Q1 FY26 to Q1 FY27 — cash reserves deplete as the company funds growth organically
Payor Mix [Cash] rises from 61.7% to 63.6% from Q1 FY26 to Q1 FY27 — higher direct patient collections reduce insurance dependency